Dies ist eine HTML Version eines Anhanges der Informationsfreiheitsanfrage 'CBD in food'.


ARES(2018)5311936
Ref. Ares(2019)6805582 - 04/11/2019
From:
 (GROW-EXT)
To:
"
Cc:
 (GROW)
Subject:
Ares(2018)5277178 - RE: Need some clarification
Date:
mardi 16 octobre 2018 10:17:51
Dear Mr. 
Thank you for your query.
We would like to inform you that the CosIng database is an inventory of cosmetic substances and
ingredients, employed for labelling cosmetic products throughout the EU. Please note that
ingredient assigned with an INCI name that appears in the inventory section of CosIng does not
mean it is to be used in cosmetic products nor approved for such use.
Entry 306 of Annex II to the Cosmetics Regulation 1223/2009 (https://eur-lex.europa.eu/legal-
content/EN/TXT/?qid=1493906428740&uri=CELEX:32009R1223) refers to "Narcotics, natural
and synthetic: All substances listed in Tables I and II of the single Convention on narcotic drugs
signed in New York on 30 March 1961".
Schedules I and II of the Convention are lists of drugs. According to Art. 1 "definitions" of the
convention, “Drug” means any of the substances in Schedules I and II, whether natural or
synthetic.
The list of drugs in Schedule I (Schedules as at 16 May 2018:
http://undocs.org/ST/CND/1/Add.1/Rev.4) includes: CANNABIS and CANNABIS RESIN and
EXTRACTS and TINCTURES OF CANNABIS.
Article 1 of the convention defines these terms as follows:
(b) “Cannabis” means the flowering or fruiting tops of the cannabis plant (excluding the seeds
and leaves when not accompanied by the tops) from which the resin has not been extracted, by
whatever name they may be designated.
(c) “Cannabis plant” means any plant of the genus Cannabis,
(d) “Cannabis resin” means the separated resin, whether crude or purified, obtained from the
cannabis plant.
We would also like to remind you that regarding the safety of cosmetic ingredients, all cosmetic
products placed on the EU market must be safe for human health. It is the responsibility of the
manufacturer (or the importer) as "responsible person" defined in Article 4 of the Cosmetics
Regulation to ensure the safety of the product. To this end, a product information file which
contains the information required under Article 11 of the Cosmetics Regulation must be kept
readily available to the competent authorities of the EU member state concerned.
The Member States are responsible for monitoring compliance with the rules laid down in the
Cosmetics Regulation via in-market controls of the cosmetic products made available on the
market (Art. 22 of the Cosmetic Regulation No 1223/2009). These controls are based on
appropriate checks of cosmetic products and checks on the economic operators on an adequate
scale, through the product information file and, where appropriate, physical and laboratory


checks on the basis of adequate samples.
 
Therefore, it is for national authorities to verify whether the cosmetic products in question
comply with the rules on safety.
 
Please note that the views expressed in this email are not legally binding; only the Court of
Justice of the EU can give an authoritative interpretation of Union law.
 
We hope you will find this information useful.
 
Best regards,
 
, PhD
 
From: 
 <
@althealifesciences.com> 
Sent: Monday, October 15, 2018 8:18 AM
To: GROW GENERAL INFORMATION <xxxxxxxxxxxxxxxxxxxxxxxx@xx.xxxxxx.xx>
Subject: Need some clarification
 
To Whom It May Concern:
 
This email is in reference to a query based on the information provided on cannabidiol
on the website
 
http://ec.europa.eu/growth/tools-databases/cosing/index.cfm?
fuseaction=search.details_v2&id=93486
 
There is a restriction of use of cannabidiol based on information presented. We would be
very grateful if you could share your insights on the restriction provided below
 
Cosmetic
II/306 =
Restriction Narcotics, natural
and synthetic: All
substances listed
in Tables I and II
of the single
Convention on
narcotic drugs
signed in New
York on 30
March 1961  
 
Can you please elaborate on the phrase above and how it applies to use of CBD in
cosmetics.
 
Thank you in advance.
 
Best Regards
Electronically signed on 31/10/2019 12:33 (UTC+01) in accordance with article 4.2 (Validity of electronic documents) of Commission Decision 2004/563